Clinical Trial Update: Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safinamide as add-on therapy to levodopa in idiopathic Parkinson's disease with motor fluctuations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• Safinamide (Safinamide)

Snippet

Sponsor: Newron Pharmaceuticals SPA | Conditions: Idiopathic Parkinson's Disease | Phase 3 | Status: COMPLETED